This is an aggregated industry headline. Read the full story at Drug Channels →
2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges
By Adam J. Fein, Ph.D. Every year, Drug Channels reviews drug pricing trends at the largest pharmaceutical manufacturers. This year's disclosures provide early evidence that the economics of the U.S. drug channel-and the strategies manufacturers use to secure market access-are beginning to change. W
By Drug Channels
· Jul 21, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Amgen has agreed to a $74 million settlement with investors to resolve a lawsuit that alleged the company hid …
The WeekFierceBiotech ↗
A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-k…
The WeekBriefing
Novo Nordisk filed suit against Eli Lilly over GLP‑1 drugs as Anthropic deepened its rare‑disease biotech work…